A. Lehmann
Impact in
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
- Molecular Biology top 10%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
- DNA and Nucleic Acid Chemistry
- Fungal and yeast genetics research
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 2
- PARP inhibition in cancer therapy 2
-
- DNA Repair Mechanisms 9
- Ubiquitin and proteasome pathways 4
- Genomics and Chromatin Dynamics 2
- Co-authors
- C.F. ArlettSusan E. CritchlowNicholas PlowmanHeather BeamishBoris KyselaBernard C. BroughtonPenny A. JeggoSoo‐Hwang Teo
- Journals
- Liver International (1 paper)Current Biology (1 paper)FEBS Letters (1 paper)Mutagenesis (1 paper)Molecular Cell (1 paper)
- Partner nations
- United KingdomJapanGermany
In The Last Decade
A. Lehmann
19 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 75
- Cancer Research 222
- Molecular Biology 907
- Oncology 196
- Cell Biology 99
- Aging 10
Countries citing papers authored by A. Lehmann
This map shows the geographic impact of A. Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lehmann more than expected).
Fields of papers citing papers by A. Lehmann
This network shows the impact of papers produced by A. Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lehmann. The network helps show where A. Lehmann may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Lehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2018 | 21 | |
| 3 | 2017 | 5 | |
| 4 | 2017 | 12 | |
| 5 | 2006 | 10 | |
| 6 | 2004 | 8 | |
| 7 | 2004 | 30 | |
| 8 | 2003 | 366 | |
| 9 | 2002 | 40 | |
| 10 | 2000 | 32 | |
| 11 | 1999 | 312 | |
| 12 | 1997 | 77 | |
| 13 | Impaired jun-NH2-terminal kinase activation by ultraviolet irradiation in fibroblasts of patients with Cockayne syndrome complementation group B. | 1996 | 11 |
| 14 | 1992 | 85 | |
| 15 | 1990 | 3 | |
| 16 | [Cells of patients with ataxia telangiectasia show a normal capacity of radio-induced reactivation of damaged HSV-1 virus]. | 1987 | 1 |
| 17 | 1985 | 4 | |
| 18 | 1978 | 13 | |
| 19 | 1977 | 2 |
About A. Lehmann
A. Lehmann is a scholar working on Oncology, Molecular Biology, Cell Biology, Cancer Research and Pharmacology, having authored 19 papers that have together received 1.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (9 papers), Ubiquitin and proteasome pathways (4 papers), Plant nutrient uptake and metabolism (2 papers), Microtubule and mitosis dynamics (2 papers), Genetics and Neurodevelopmental Disorders (2 papers), Cancer-related Molecular Pathways (2 papers), PARP inhibition in cancer therapy (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Cancer Research (222 citations), Molecular Biology (907 citations), Oncology (196 citations), Cell Biology (99 citations) and Aging (10 citations). A. Lehmann has collaborated with scholars based in United Kingdom, Japan and Germany. Frequent co-authors include C.F. Arlett, Susan E. Critchlow, Nicholas Plowman, Heather Beamish, Boris Kysela, Bernard C. Broughton, Penny A. Jeggo, Soo‐Hwang Teo, Stephen P. Jackson and A. Priestley. Their work appears in journals such as Liver International, Current Biology, FEBS Letters, Mutagenesis and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.